A diabetes‐associated genetic variant is associated with diastolic dysfunction and cardiovascular disease

Although the epidemiological association between Type 2 diabetes and congestive heart failure (CHF) as well as cardiovascular disease (CVD) is well established, associations between diabetes‐related single‐nucleotide polymorphisms (SNPs), CHF, and CVD have been surprisingly inconclusive. Our aim is to examine if 43 diabetes‐related SNPs were associated with prevalent diastolic dysfunction assessed by echocardiography and incident CVD and/or CHF.

[1]  L. Vallier,et al.  The role of hepatocyte nuclear factor 1β in disease and development , 2016, Diabetes, obesity & metabolism.

[2]  J. Florez,et al.  Type 2 Diabetes Genetic Predisposition, Obesity, and All-Cause Mortality Risk in the U.S.: A Multiethnic Analysis , 2016, Diabetes Care.

[3]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[4]  C. Gieger,et al.  Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. , 2015, Atherosclerosis.

[5]  C. Greenwood,et al.  A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease , 2015, Nature Communications.

[6]  M. Fornage,et al.  Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study , 2015, Circulation. Cardiovascular genetics.

[7]  A. Hattersley,et al.  HNF1B-associated renal and extra-renal disease—an expanding clinical spectrum , 2015, Nature Reviews Nephrology.

[8]  Brooke L. Fridley,et al.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer , 2013, Nature Genetics.

[9]  F. Hu,et al.  Diabetes Genetic Predisposition Score and Cardiovascular Complications Among Patients With Type 2 Diabetes , 2013, Diabetes Care.

[10]  Peter Kraft,et al.  Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium. , 2012, American journal of epidemiology.

[11]  F. Rutten,et al.  High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes , 2012, Diabetologia.

[12]  Ramachandran S Vasan,et al.  Diabetes and the risk of heart failure. , 2012, Heart failure clinics.

[13]  R. Luben,et al.  Individual and cumulative effect of type 2 diabetes genetic susceptibility variants on risk of coronary heart disease , 2011, Diabetologia.

[14]  J. Coresh,et al.  The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study , 2010, Diabetes.

[15]  V. Gudnason,et al.  Myocardial structure and function by echocardiography in relation to glucometabolic status in elderly subjects from 2 population-based cohorts: a cross-sectional study. , 2010, American heart journal.

[16]  W. Paulus,et al.  The failing diabetic heart: Focus on diastolic left ventricular dysfunction , 2009, Current Diabetes Reports.

[17]  Arturo Evangelista,et al.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[19]  M. Ridderstråle,et al.  BMC Cardiovascular Disorders BioMed Central , 2008 .

[20]  Kristin G Ardlie,et al.  Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes , 2007, Diabetes.

[21]  E. Ingelsson,et al.  The validity of a diagnosis of heart failure in a hospital discharge register , 2005, European journal of heart failure.

[22]  E. Ingelsson,et al.  Insulin resistance and risk of congestive heart failure. , 2005, JAMA.

[23]  Julio E. Pérez,et al.  Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. , 2004, The American journal of cardiology.

[24]  W. Hundley,et al.  Heart failure prevalence, incidence, and mortality in the elderly with diabetes. , 2004, Diabetes care.

[25]  W. Kannel,et al.  Incidence and Epidemiology of Heart Failure , 2000, Heart Failure Reviews.

[26]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[27]  B. Howard,et al.  Mitral Ratio of Peak Early to Late Diastolic Filling Velocity as a Predictor of Mortality in Middle-Aged and Elderly Adults: The Strong Heart Study , 2002, Circulation.

[28]  M Rosén,et al.  A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. , 2001, International journal of epidemiology.

[29]  J. Gardin,et al.  Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. , 2001, Journal of the American College of Cardiology.

[30]  F. Maklady,et al.  Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. , 2001, The American journal of cardiology.

[31]  A. Hattersley,et al.  Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. , 2001, American journal of human genetics.

[32]  D L McGee,et al.  Diabetes and Cardiovascular Risk Factors: The Framingham Study , 1979, Circulation.